Team:Hong Kong HKUST/notebook/mod1

From 2013.igem.org

(Difference between revisions)
Line 50: Line 50:
{
{
position:fixed;
position:fixed;
-
top:150px;
+
top:300px;
left:10px;
left:10px;
}
}
Line 78: Line 78:
</style>
</style>
<style type="text/css">
<style type="text/css">
-
ody{background-color:#494042;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;}
+
body{background-color:#d5cfbf;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;font: x-small sans-serif;}
#menubar  
#menubar  
{background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
{background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
Line 89: Line 89:
#p-logo
#p-logo
{visibility:hidden;}
{visibility:hidden;}
-
h1, h2, h3, h4, h5, h6 {
 
-
font-family:"Trebuchet MS", Helvetica, sans-serif
 
-
font-weight: normal;
 
-
color: #000;
 
-
border-bottom: none;
 
-
}
 
-
h1{font-size:14px;}
 
.firstHeading
.firstHeading
{visibility:hidden;}
{visibility:hidden;}
Line 109: Line 102:
{display:none}
{display:none}
#kepala
#kepala
-
{position:absolute;top:15px;background-color:#F0A5BE;height:121px;width:100%;}
+
{position:absolute;top:15px;background-color:#F0A5BE;}
-
#copyright
+
#cover
-
{position:absolute;left:325px;top:630px;}
+
{position:absolute;top:0px;height:168px;width:100%;background:#494042;z-index:-1;}
 +
body, div, dl, dt, dd, ul, ol, li, h1, h2, h3, h4, h5, h6, pre, form, fieldset, p, blockquote, th, td {
 +
margin: 0;
 +
padding: 0;
 +
font-size: 14px;
 +
}
 +
* {
 +
-webkit-box-sizing: border-box;
 +
-moz-box-sizing: border-box;
 +
box-sizing: border-box;
 +
}
 +
div.menu
 +
{
 +
width:100%;
 +
}
 +
.row {
 +
width: 940px;
 +
max-width: 100%;
 +
min-width: 768px;
 +
margin: 0 auto;
 +
 
 +
}
 +
.row:after {
 +
clear: both;
 +
}
 +
.row:before, .row:after {
 +
content: "";
 +
display: table;
 +
}
.menu ul,li
.menu ul,li
{
{
Line 118: Line 139:
list-style:none;
list-style:none;
width:100%;
width:100%;
 +
z-index:11;
}
}
ul.first>li
ul.first>li
{
{
float:left;
float:left;
-
width:16.66%;
+
width:16.6667%;
 +
z-index:11;
}
}
ul.first>li>a:link,ul.first>li>a:visited
ul.first>li>a:link,ul.first>li>a:visited
Line 134: Line 157:
text-decoration:none;
text-decoration:none;
text-transform:uppercase;
text-transform:uppercase;
 +
z-index:11;
}
}
ul.first>li>a:hover,ul.first>li>a:active
ul.first>li>a:hover,ul.first>li>a:active
{
{
-
background-color:#e32e51;
+
background-color:#e32e51;z-index:11;
}
}
Line 144: Line 168:
{
{
display:none;
display:none;
-
width:100%;
+
width:100%;z-index:11;
}
}
Line 157: Line 181:
text-decoration:none;
text-decoration:none;
text-transform:uppercase;
text-transform:uppercase;
 +
z-index:11;
}
}
ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active
ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active
{
{
-
background-color:#f87790;
+
background-color:#f87790;z-index:11;
}
}
.menu
.menu
Line 169: Line 194:
top:141px;
top:141px;
width:100%;
width:100%;
 +
z-index:11;
 +
}
 +
ul.side-nav {
 +
display: block;
 +
list-style: none;
 +
margin: 0;
 +
padding: 17px 0;
 +
}
 +
ul.side-nav h6 {
 +
margin: 47px 0px 0px;
 +
}
 +
ul.side-nav li.divider {
 +
border-top: 1px solid #ddd;
 +
}
 +
.two, .row .two {
 +
width: 16.66667%;
 +
top:160px;
}
}
ul, ol {
ul, ol {
-
line-height: 1.6;
 
font-size: 14px;
font-size: 14px;
 +
line-height: 1.6;
 +
}
 +
[class*="column"] + [class*="column"]:last-child {
 +
float: right;
 +
}
 +
.ten, .row .ten {
 +
width: 83.33333%;
 +
top:192px;
 +
z-index:-2;
 +
}
 +
.column, .columns {
 +
float: left;
 +
min-height: 1px;
 +
padding: 0 15px;
 +
position: relative;
 +
}
 +
.twelve, .row .twelve {
 +
width: 100%;
 +
}
 +
h1, h2, h3, h4, h5, h6 {
 +
font-family:"Trebuchet MS", Helvetica, sans-serif
 +
font-weight: normal;
 +
color: #000;
 +
border-bottom: none;
 +
}
 +
div.team-bios-container div.row {
 +
padding: 0px 0px 10px;
 +
border-bottom: 1px solid #ddd;
 +
}
 +
.row .row {
 +
width: auto;
 +
max-width: none;
 +
min-width: 0;
 +
margin: 0 -15px;
 +
}
 +
media="screen, projection"
 +
#bodyContent h1, #bodyContent h2 {
 +
margin-bottom: .6em;
 +
}
 +
h1.centered, h2.centered, h3.centered, h4.centered, h5.centered, h6.centered {
 +
text-align: center;
 +
}
 +
h2 {
 +
font-size: 37px;
 +
}
 +
.nine, .row .nine {
 +
width: 75%;
 +
}
 +
[class*="column"] + [class*="column"]:last-child {
 +
float: right;
 +
}
 +
.three, .row .three {
 +
width: 25%;
}
}
#flight{z-index:-2;}
#flight{z-index:-2;}
Line 183: Line 277:
<ol class="pos_fixed">
<ol class="pos_fixed">
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook">Notebook</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook">Notebook</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod2">Module 1</a></li>
+
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod1">Module 1</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod2">Module 2</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod2">Module 2</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod3">Module 3</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod3">Module 3</a></li>

Revision as of 22:39, 27 September 2013

  1. Notebook
  2. Module 1
  3. Module 2
  4. Module 3
  5. Module 4








FA Quantification and Cell Viability Module's Notebook

June 2013

Week 4

 

June 25:

  • Prepared DMEM in TC room
  • Added FBS (Serum) & Antibiotics into DMEM

 

June 27:

  • Designed the experiment for testing FA concentration by GCMS

 

June 28:

  • HepG2 cell culturing (first generation)

July 2013

Week 1

 

July 2:

  • HepG2 cell passaging
  • Made sodium palmitate from powder to solution by 50% Ethanol

 

July 3:

  • Used GCMS to quantify the FA in the medium

 

July 4:

  • Passaged HepG2 cells
  • Changed medium for cell line
  • Searched for information of MTT assay and Transfection by lipofectamine
  • Got GCMS results for the last day: Not accurate/usable

 

July 5:

  • Repeated GCMS test again testing FA in medium and we made
  • Got the result of GCMS: Not accurate/usable

 

Week 2

 

July 8:

  • Passaged HepG2 cells
  • Used some HepG2 cells to extract genomic DNA

 

July 9:

  • Another try of GCMS with a gradient concentration of FA
  • Got the result of GCMS: Not match with the concentration we made

 

July 10:

  • Repeated GCMS: No accurate results
  • Changed medium for the cell line
  • Checked lipofectamine protocol

 

July 11:

  • GCMS again for the same sodium palmitate we made: No accurate results
  • Passaged HepG2 cell line

 

July 12:

  • Prepared reagents for MTT assay for cell viability test, protocols checked
  • Changed the medium of the cell line

 

Week 3

 

July 15:

  • Seeded HepG2 cells into 96-well plate for MTT cell viability test and adding FA
  • Seeded HepG2 cells into 96-well plate for transfection of PEGFP-N1

 

July 16:

  • Transfection of PEGFP-N1 into HepG2 cells
  • Passaged HepG2 cells

 

July 17:

  • Changed the medium after transfection had been done in 24 hours
  • Did MTT assay and getting result (adding FA in the wrong time, cannot be used)
  • Made new DMEM
  • Changed medium for the cell line

 

July 18:

  • Seeded HepG2 cells in 24-well plate for transfection of PEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Got polylysine for coating

 

July 19:

  • Changed the medium for the HepG2 cell line
  • Seeded cells for another MTT assay
  • Checked HepG2 cells for transfection: growing slow, 30% confluency, cannot do transfection
  • Seeded cells on a 96-well plate for transfection in the coming week
  • Passaged HepG2 cells

 

Week 4

 

July 22:

  • Transfection of PEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP on 96-well plate
  • Added gradient concentration of sodium palmitate into HepG2 cells for MTT assay
  • Coated coverslips with polylysine for HepG2 cell staining and fixation

 

July 23:

  • Replaced the medium after transfection of PEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Finished MTT assay to get cell viability in different FA concentrations in 24 hours
  • Transferred cells containing PEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP into 24-well plate with well-coated coverslips in each well

 

July 24:

  • Stained mitochondria by Mito-tracker@Red and fixating by formaldehyde of HepG2 cells transfected with pEGFP-N1, pCMV/myc/mito/EGFP and Pmv/myc/mito/GFP in 24-well plate
  • Passaged HepG2 cells and changed medium of the cell line

 

July 25:

  • Got results for cell staining and fixation: No obvious overlapping pattern between GPF signal and Mito-tracker red.

 

July 26:

  • Coated coverslips by polylysine
  • Seeded HepG2 cells in one 24-well plate for transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Seeded HepG2 cells on two 96-well plate, for transfection of FABP construct and MTT assay in 48 hours

 

Week 5

 

July 29:

  • Transfection of FABP construct with pEGFP-N1 as control
  • Transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP in 24-well plate with well-coated coverslips
  • Added gradient concentration form 0.1mM to 1.2mM of FA into the plate for MTT assay

 

July 30:

  • Changed medium after transfection of pEGFP-N1 and FABP construct and saw the results: Both pEGFP-N1 and FABP construct did not show GFP signals
  • Changed medium after transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Did staining and fixation of the coverslips and saw the results: No obvious overlapping patterns of GFP signals and Mito-tracker red
  • Passaged HepG2 cells

 

August 2013

Week 1

 

Aug 1:

  • Seeded cells for transfection of pEGFP-N1, FABP construct, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Changed medium for HepG2 cell line
  • Got results for MTT assay in 48 hours

Aug 2:

  • Checked if transfection (after 22 hrs) worked
    • No GFP signal for pEFGP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP

     

Week 2

 

Aug 5:

  • Transfection of HepG2 cells on 10cm Plates
  • Passaged P(n+8) HepG2 cells into one P(n+9)
  • Seeded HepG2 cells on 96-well plates for transfection

 

Aug 6:

  • Trouble shooting for transfection of HepG2 cells on 96 well plates

 

Aug 7:

  • Observe transfected cell. GFP signal expressed
  • Seeded cells for transfection of pEGFP-N1, and (FABP construct/EGFP) in 96 well-plate
  • Seeded cells for transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP in 24 well plate with polylysine coated coverslips
  • Seeded cells for MTT assay

 

Aug 8:

  • Observed transfection of pEGFP-N1, and (FABP construct/EGFP) in 96 well-plate. No GFP signal observed
  • Observed transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP. GFP signal observed
  • Stained mitochondria of cells transfected with pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP using mito tracking dye
  • Observed cell with both transfection and stained mitochondria: No GFP signal observed because transfection occurred with very low efficiency.
  • Prepared new cell line: HEK293FT
  • Conducted MTT assay

 

Week 3

 

Aug 12:

  • MTT Assay without seeding and incubation
  • Changed medium for HepG2 and HEK293FT cell lines
  • Prepared polylysine coated coverslips

 

Aug 13:

  • Seeded cells using HEK293FT cell line for transfection

 

Aug 15:

  • Cells detached and not in good condition for transfection

 

Aug 16:

  • Seeded cells HEK293FT cell line for transfection

 

Week 4

 

Aug 19:

  • Transfection of pEGFP-N1, and (FABP construct/EGFP) in 96 well plate and pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP in 24 well plate.

 

Aug 20:

  • Seeing results of transfection of FABP construct and pEGFP-N1 in HEK293FT cells and seeing the results: pEGFP-N1 had signal but FABP did not show GFP signals

 

Aug 22:

  • Transfection of pEGFP-N1 and FABP construct into HEK293FT cells
  • Changing medium for HEK293FT cells and HepG2 cells and seeing the results: pEGFP-N1 had signal but FABP did not show GFP signals

 

Week 5

 

Aug 26:

  • Transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP in 60mm TC plates
  • Changing medium of transfection of the previous day and seeing the results: pEGFP-N1 had signal but FABP did not show GFP signals

 

Aug 28:

  • Changing medium of transfection of the previous day
  • Staining and fixation of
  • Drawing MTT standard curves

 

Aug 29:

  • Transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP into HEK293FT cells
  • Maintaining HEK293FT and HepG2 cell line

 

Aug 30:

  • Staining and fixation for HEK cells transfected by pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Seeing the results for transfected HEK293FT cells: No obvious overlapping pattern of GFP signals and Mito-tracker
  • Seeding HepG2 cells for Transfection of FABP construct and pEGFP-N1 in 96-well plate
  • Seeding HEK 293FT cells for transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Passaging HEK293FT cell line

 

Aug 31:

  • Transfection with pEGFP-N1 and pCMV/PolyA/EGFP into HEK293FT cells

 

September 2013

Week 1

 

Sept 1:

  • Checking results for transfection on Aug 31: pEGFP-N1 had strong signal while PolyA did not have signals

 

Sept 2:

  • Transfection of FABP construct and pEGFP-N1 in HepG2 cells
  • Check results for HEK293FT cells been transfected by pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP, by using confocal microscope

 

Sept 3:

  • Adding FA into HepG2 cells been transfected by FABP construct and pEGFP-N1
  • Maintaining HepG2 and HEK293FT cell line
  • Drug selection Test on HEK293FT test by purmycin

 

Sept 4:

  • Drug selection test on HEK293FT cells by neomycin and puromycin

 

Sept 5:

  • Staining and fixation of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP and seeing he results by confocal microscope
  • Making mew DMEM
  • Drug selection test observation

 

Sept 6:

  • Transfection of FAPB and pEGFP-N1 into HepG2 cells in 60 mm plates
  • Maintaining cell line for HEK293FT cells

 

Sept 7:

  • Checking results for transfection on Sept 6: pEGFP-N1 showed weak GFP signal, no signals for FABP
  • Change medium for drug selection test

 

Sept 8:

  • Maintaining cell line for HEK293FT cells and HepG2 cells

 

Week 2

 

Sept 9:

  • Checking transfection for FABP construct again: Weak signals were shown from the debris of the cells
  • Transfection of AceA construct

 

Sept 11:

  • Seeding HEK293FT cells into 35mm plates for transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP
  • Cell splitting of ACE

 

Sept 12:

  • Transfection of pEGFP-N1, pCMV/myc/mito/EGFP and pCMV/myc/mito/GFP into HEK293FT cells

 

Week 3
Content 1
Week 4
Content 1
Week 5
Content 1

Retrieved from "http://2013.igem.org/Team:Hong_Kong_HKUST/notebook/mod1"